Sevoflurane Relieves Lung Function Deterioration After Cardiopulmonary Bypass.

Area of Science:

• Anesthesiology and Critical Care Medicine
• Cardiovascular Surgery
• Pulmonary Medicine

Background:

• Cardiopulmonary bypass (CPB) can lead to significant pulmonary complications.
• These complications include bronchoconstriction, impaired lung mechanics, and increased intrapulmonary shunting.
• Effective management strategies are crucial to mitigate these adverse effects.

Purpose of the Study:

• To evaluate the efficacy of sevoflurane in ameliorating pulmonary dysfunction post-CPB.
• To investigate sevoflurane's impact on lung mechanics and gas exchange after cardiac surgery.
• To determine if sevoflurane provides greater benefits in patients with more severe CPB-induced lung injury.

Main Methods:

• Prospective, randomized clinical trial involving 190 patients undergoing elective cardiac surgery.
• Patients received either sevoflurane (1 MAC for 5 minutes post-CPB) or continued intravenous anesthesia.
• Lung mechanical impedance, capnography, blood gas analysis, and lung compliance were measured.

Main Results:

• Sevoflurane administration post-CPB resulted in significant bronchodilation, indicated by reduced airway resistance.
• Improvements were observed in lung tissue viscoelasticity (decreased tissue damping and elastance).
• Sevoflurane increased the PaO2/FiO2 ratio and lung compliance while decreasing the capnogram phase III slope and shunt fraction.

Conclusions:

• Sevoflurane effectively alleviates CPB-induced bronchoconstriction and compromised lung tissue mechanics.
• The anesthetic agent also reduces intrapulmonary shunting after cardiopulmonary bypass.
• The benefits of sevoflurane are particularly pronounced in patients experiencing severe lung function deterioration post-CPB.